Dabigatran, the oral anticoagulant of choice at discharge in patients with non-valvular atrial fibrillation and COVID-19 infection: the ANIBAL protocol

Atrial fibrillation is a frequent complication among patients with severe coronavirus disease-2019 (COVID-19) infection. Both direct and indirect mechanisms through COVID-19 have been described to explain this relationship. COVID-19 infection increases the risk of developing both arterial and venous...

Descripción completa

Detalles Bibliográficos
Autores principales: Iturbe-Hernandez, Teodoro, García de Guadiana Romualdo, Luis, Gil Ortega, Ignacio, Martínez Francés, Antonio, Meca Birlanga, Olga, Cerezo-Manchado, Juan José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioExcel Publishing Ltd 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505118/
https://www.ncbi.nlm.nih.gov/pubmed/33014097
http://dx.doi.org/10.7573/dic.2020-8-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505118/
https://www.ncbi.nlm.nih.gov/pubmed/33014097
http://dx.doi.org/10.7573/dic.2020-8-3

Ejemplares similares